Kalaris Therapeutics Inc

Kalaris Therapeutics Inc

KLRS
Kalaris Therapeutics IncUS flagNASDAQ Global Market
4.04
USD
+0.04
- -
75.56MMarket Cap

Kalaris Therapeutics Inc (KLRS) Stock Split History

Learn about Kalaris Therapeutics Inc's most recent 1-for-23 basis stock split on January 16, 2025. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Kalaris Therapeutics Inc's most recent stock split

Split Date: 2025-01-16
Split Ratio: 1:23
Price Before Split: $0.39
Price After Split: $0.02

Developer API

Get KLRS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/KLRS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 23.00 times fewer shares (a 1:23 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Kalaris Therapeutics Inc's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-01-161:23Yes$0.39$0.02

About Kalaris Therapeutics Inc

Company overview and industry information

Kalaris Therapeutics Inc (KLRS) operates in the Biotechnology industry. The recent 1-for-23 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Kalaris Therapeutics Inc Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.